Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference

PORTLAND, Ore., June 19, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Operating Officer will present a corporate update at the 9th Annual JMP Securities Healthcare Conference. The presentation will take place on Wednesday, June 25, 2014 at 2:30 p.m. ET at the Westin Grand Central Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq: GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit: www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Vice President, Marketing & Communications
         (503) 405-8258
         [email protected]

You May Also Be Interested In

• Transform Your Weight Loss Journey with the Portions Master AI App: Redefining Healthy Eating through Portion AI Technology
• AM Best Downgrades Credit Ratings of Members of Columbian Financial Group; Maintains Under Review With Negative Implications Status
• SponsorUnited Unveils 3.0, a New Level of Data-Driven Partnership Intelligence